Nrx Pharmaceuticals Inc (NRXP) Stock Price, Quote & News

Company Profile

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-f...

Industry: Biotechnology

Sector: Healthcare

Phone: 484 254 6134

Website: www.nrxpharma.com

Address:

1201 Orange Street, Suite 600, Wilmington, United States

DavidBG Jun. 15 at 10:58 AM

$NRXP I've been surprised in private discussions with some other posters by the lack of importance attributed to the ANDA filing, which is a very solid short-term path to revenue and on which there is now a regulatory clock counting down. I get that the upcoming NDAs and clinic acquisition closings are more exciting, though.

1 · Reply

FounderV Jun. 15 at 10:01 AM

$NRXP https://www.fox16.com/business/press-releases/accesswire/1039605/new-to-the-street-episode-671-airs-tonight-on-bloomberg-television-at-630-pm-est-featuring-floki-arrive-ai-nasdaq-arai-health-in-tech-nasdaq-hit-vita-bella-and-nrx-pharmaceuticals-nasdaq/

0 · Reply

Diamondnutzzzz Jun. 15 at 12:22 AM

$NRXP 35 million in an age of the most corrupt “unsuccessful” pharma/scam. Oh…Israel. How was it working for the Clintons?

2 · Reply

larumba Jun. 14 at 12:46 PM

$NRXP @DavidBG has made a killing shorting this ticker over the years. The only person around here happy with Javitts performance is Javitt, his honest investors, Anson Funds, and DavidBG. While DavidBG is pumping and defending a company that’s lost over 99% of its value from top to bottom - he’s been shorting this stock every bump and making a fortune. Read through his posts and re-posts on Stocktwits the last few years. Then look at the stock chart. Longs are not happy with the chart and management- shorts like Anson and DavidBG love it. So obvious…… When that successful bio tech fund manager said DavidBG couldn’t find water if he fell out of a boat….what he didn’t know is Andrew Left is DavidBG’s idol. For those not familiar - read up on Anson Funds ( Javitts financial partner) and Lefts relationship. https://www.justice.gov/criminal/criminal-vns/case/united-states-v-andrew-left

1 · Reply

FounderV Jun. 14 at 6:54 AM

$NRXP I understand that the drug this company is developing is for the treatment of post-war trauma for veterans and war victims. I hope the war ends soon.

0 · Reply

jonny80s Jun. 14 at 3:12 AM

$NRXP 10 business days left for a whole lot of expected catalysts to play out. If we get 1 NDA submitted “in full” and 1 clinic acquisition I’ll be surprised. Put up or shut up. LFG @JavittMD !!!

1 · Reply

surfsup11 Jun. 14 at 2:14 AM

$NRXP https://apnews.com/press-release/getnews/750-million-market-projected-to-reach-3-35-billion-globally-in-2034-for-abbreviated-new-drug-application-filed-on-preservative-free-iv-ketamine-nrx-pharmaceuticals-inc-nasdaq-nrxp-b600e9035f4b8307a634790b45bb6a63

1 · Reply

AIIAAIIA_88 Jun. 13 at 8:56 PM

$NRXP Get the patent and get the clinical network and get the FDA letter of NDA acceptance for NRX-100. All by June 30 to keep your words and to become credible and trustworthy. That is all. Please. Then the stock should be above $12. JMO

0 · Reply

fuctonfauci Jun. 13 at 7:03 PM

$NRXP an other friday, an other week, little to no success. 10 days to prove otherwise.... what a useless management... “not this year next year”

1 · Reply

larumba Jun. 13 at 1:39 PM

$NRXP https://ir.nrxpharma.com/2025-01-28-NRx-Pharmaceuticals,-Inc-NASDAQ-NRXP-Advances-Relationship-with-Anson-Funds-with-8-9-Million-Financing,-Including-Above-the-Market-Equity-and-Senior-Secured-Debt

2 · Reply

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Jun 5, 2025, 8:03 AM EDT - 10 days ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine

May 16, 2025, 8:46 PM EDT - 4 weeks ago

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

May 15, 2025, 4:03 PM EDT - 4 weeks ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 15, 2025, 10:15 AM EDT - 4 weeks ago

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions

May 13, 2025, 8:03 AM EDT - 4 weeks ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics

May 12, 2025, 8:03 AM EDT - 4 weeks ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025

May 6, 2025, 8:03 AM EDT - 5 weeks ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025

May 5, 2025, 8:03 AM EDT - 5 weeks ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine

Apr 30, 2025, 8:46 AM EDT - 6 weeks ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression

Apr 21, 2025, 8:01 AM EDT - 7 weeks ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025

Apr 3, 2025, 8:03 AM EDT - 2 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE

Mar 31, 2025, 8:02 AM EDT - 2 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry Clinics

Mar 24, 2025, 8:02 AM EDT - 2 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics

Mar 17, 2025, 10:50 AM EDT - 3 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 8:02 AM EDT - 3 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 8:01 AM EDT - 3 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 17, 2025

Feb 6, 2025, 8:03 AM EST - 4 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc. to Present at the Oppenheimer 35th Annual Healthcare Conference on February 12, 2025

Feb 3, 2025, 8:59 AM EST - 4 months ago

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor

Jan 28, 2025, 8:05 AM EST - 4 months ago

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition

Jan 28, 2025, 8:03 AM EST - 4 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Advances Relationship with Anson Funds with $8.9 Million Financing, Including Above the Market Equity and Senior Secured Debt

Jan 21, 2025, 8:02 AM EST - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement

Jan 15, 2025, 8:02 AM EST - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces the Appointment of Michael Taylor to its Board of Directors and Appointment of Anita Nunes as Board Observer; Ms. Nunes to be Appointed Director of HOPE Therapeutics, Inc.

Jan 14, 2025, 8:03 AM EST - 5 months ago

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel

Jan 13, 2025, 8:04 AM EST - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces it has Filed an Application with NASDAQ to Uplist to the NASDAQ Global Market from the NASDAQ Capital Market

Jan 8, 2025, 10:20 AM EST - 5 months ago

Central Nervous System (CNS) Therapeutics Market Forecast (2025-2035) by Disease, Drug Class, Distribution Channel and Region

Jan 7, 2025, 8:07 AM EST - 5 months ago

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco

Jan 6, 2025, 10:16 AM EST - 5 months ago

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations

Jan 6, 2025, 8:03 AM EST - 5 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announce Dura Medical as the Expected Initial Florida Acquisition for its Planned International Network of Interventional Psychiatry Clinics

Jan 2, 2025, 8:03 AM EST - 5 months ago

Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics

Dec 30, 2024, 8:03 AM EST - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression

Nov 26, 2024, 8:03 AM EST - 7 months ago

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024

Nov 25, 2024, 8:03 AM EST - 7 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"

Nov 18, 2024, 7:51 PM EST - 7 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call Transcript

Nov 18, 2024, 4:05 PM EST - 7 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer

Nov 14, 2024, 4:05 PM EST - 7 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update

Nov 13, 2024, 8:03 AM EST - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024

Nov 7, 2024, 4:06 PM EST - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024

Oct 30, 2024, 7:47 AM EDT - 8 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics

Oct 3, 2024, 6:55 AM EDT - 9 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic

Sep 30, 2024, 7:00 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)

Sep 11, 2024, 7:55 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com

Sep 3, 2024, 7:55 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024

Aug 26, 2024, 7:55 AM EDT - 10 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics

Aug 15, 2024, 2:39 PM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:01 PM EDT - 10 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update

Aug 13, 2024, 4:01 PM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarter and Year to Date 2024 Financial Results on August 14, 2024

Aug 13, 2024, 7:30 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Up to $16 Million Senior Secured Debt Financing from Anson Funds

Jul 29, 2024, 8:35 AM EDT - 11 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine)

Jul 29, 2024, 8:30 AM EDT - 11 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (Nasdaq:NRXP) Announce Arbitration Order Enabling HOPE Therapeutics Spinoff

DavidBG Jun. 15 at 10:58 AM

1 · Reply

FounderV Jun. 15 at 10:01 AM

0 · Reply

Diamondnutzzzz Jun. 15 at 12:22 AM

$NRXP 35 million in an age of the most corrupt “unsuccessful” pharma/scam. Oh…Israel. How was it working for the Clintons?

2 · Reply

larumba Jun. 14 at 12:46 PM

1 · Reply

FounderV Jun. 14 at 6:54 AM

$NRXP I understand that the drug this company is developing is for the treatment of post-war trauma for veterans and war victims. I hope the war ends soon.

0 · Reply

jonny80s Jun. 14 at 3:12 AM

1 · Reply

surfsup11 Jun. 14 at 2:14 AM

1 · Reply

AIIAAIIA_88 Jun. 13 at 8:56 PM

0 · Reply

fuctonfauci Jun. 13 at 7:03 PM

$NRXP an other friday, an other week, little to no success. 10 days to prove otherwise.... what a useless management... “not this year next year”

1 · Reply

larumba Jun. 13 at 1:39 PM

2 · Reply

larumba Jun. 13 at 1:37 PM

$NRXP https://marketfrauds.to/

1 · Reply

FahadX454 Jun. 13 at 10:38 AM

$NRXP Another global conflict , any hit like this create dips like 2-3 ago

2 · Reply

dontfeedthebashers Jun. 13 at 8:27 AM

$NRXP

0 · Reply

jonny80s Jun. 12 at 8:15 PM

$NRXP I’m beginning to believe that Javitt doesn’t have the appropriate trial data that he says he has. I’m now convinced that he is “hoping” to prove bio equivalence and get preservative free ketamine approved for current indications. After that gets approved he will then push to expand the indications to PTSD, suicidal, etc. I give the NDA submission for NRX-100 a 1% chance of happening before the FDA’s ANDA decision. @JavittMD

4 · Reply

NetworkNewsWire Jun. 12 at 7:14 PM

BioMedNewsBreaks – $NRXP and HOPE Therapeutics to Present at H.C. Wainwright Neuro Perspectives Conference https://ibn.fm/Uv4GC

0 · Reply

NetworkNewsWire Jun. 12 at 6:48 PM

$NRXP Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage https://ibn.fm/ji1Ro

0 · Reply

larumba Jun. 12 at 6:02 PM

$NRXP true or false ? the 27 million dollar financier bailed when he learned more about you and your business dealings - did he not? No different than board members, CEO, scientific board members, Alvogen and Lotus. The list of your fraudulent claims- gets longer by the day. You didn’t close 35 million dollars the only person you’re kidding is yourself, friends, family and your honest investors. You and DavidBG are something……..

2 · Reply

AIIAAIIA_88 Jun. 12 at 5:30 PM

$NRXP When is the PDUFA dates for HTX-100 and NRX-101? Are they set yet or still waiting from FDA? THX

1 · Reply

jonny80s Jun. 12 at 5:04 PM

$NRXP and the floor has now become the ceiling. @JavittMD spreading “Hope” in that interview, but shying away from putting anything in stone…. Good old Javitt: has nothing and will pump the hell out of it! Why not submit the NDA for 100??? It is free and would certainly get the share price to a significantly more attractive level for this offering….. When arguments do not make sense…..

3 · Reply

BigJohn57 Jun. 12 at 3:42 PM

$NRXP You can’t kill quality!

0 · Reply

systemish Jun. 12 at 3:00 PM

$NRXP The magnetic pull of 33 cents.

1 · Reply

Lunatics Jun. 12 at 2:29 PM

$NRXP Lets see if it materialises...

1 · Reply

Market Cap	59.47M
Revenue (ttm)	0.00
Net Income (ttm)	-25.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	358,000
Avg Vol	268,026
Day's Range	N/A - N/A
Shares Out	17.29M
Stochastic %K	70%
Beta	1.54
Analysts	Strong Sell
Price Target	$28.50